GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction
Aging · 2024
DOI: 10.18632/aging.205774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Jingtong Zeng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms, Immunotherapy, Connexins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
- Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
- Colleges of Nursing, Tianjin Medical University, Tianjin, China.
Zitieren
APA
Zeng, J., Li, X., Zhang, Y., Zhang, B., Wang, H., Bao, S., Zu, L., Zhang, H., Cheng, Y., Tang, Q., Xu, X., Xu, S., & Song, Z. (2024). GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction. Aging. https://doi.org/10.18632/aging.205774
Vancouver
Zeng J, Li X, Zhang Y, Zhang B, Wang H, Bao S, et al. GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction. Aging. 2024. doi:10.18632/aging.205774
BibTeX
@article{Zeng2024,
author = {Zeng, Jingtong and Li, Xianjie and Zhang, Yifan and Zhang, Bo and Wang, Hanqing and Bao, Shihao and Zu, Lingling and Zhang, Hao and Cheng, Yuan and Tang, Quanying and Xu, Xiaohong and Xu, Song and Song, Zuoqing},
title = {GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205774}
}
EUVIMED